LONDON, May 19, 2011 /PRNewswire/ -- Business Monitor International (BMI) has announced its latest report, China Pharmaceuticals & Healthcare Report.
The healthcare and pharmaceutical analysis (http://analysis.businessmonitor.com/intelligence/all-regions/all-countries/pharmaceuticals-healthcare) includes Business Monitor International's five and ten year forecast for drugs and healthcare expenditure, imports and exports, and focuses on the growth outlook for the prescription, OTC, patented drugs and generics market segments. The forecasts are based on in depth analysis into industry trends and new developments.
The China Analysis (http://analysis.businessmonitor.com/intelligence/asia/china/all-industries) report is designed to provide industry professionals, market investors and corporate and financial services analysts with independent forecasts and competitive intelligence on the Chinese pharmaceutical and healthcare industry. The report is vital to these groups so that they can benchmark BMI's independent five and ten year pharmaceutical and healthcare industry forecasts on China, target business opportunities and risks in the Chinese pharmaceutical and healthcare sector and assess the activities, strategy and market position of pharmaceutical competitors, partners and clients.
Following the outcome of Q1 2011, BMI now predicts China will become the most attractive pharmaceutical market in Asia Pacific within the next five years. China has the world's most attractive emerging pharmaceutical market. Driven by a booming economy and underpinned by political stability, demand for medicines, both generic and patented, will continue to increase. However - the key downside risk is further pricing pressures, which could intensify in the event of an economic slowdown.
About Business Monitor International (http://analysis.businessmonitor.com/):
Business Monitor International (BMI) is a leading, independent provider of proprietary data, industry reports (http://analysis.businessmonitor.com/intelligence/all-regions/all-countries/all-industries) ratings, rankings and forecasts covering 175 countries and 22 industry sectors.
BMI's customers and clients span more than 140 countries worldwide, including more than 400 of the Global Fortune 500 companies. Businesses, banks, financial service companies, governments, academia and research centres have all come to rely on BMI's analysis, data and forecasts - and have done so for 25 years. The company was awarded the Queen's Award for Export Achievement in 1997.
BMI is a wholly independent company, headquartered at Blackfriars, London, with foreign offices in Singapore and New York.
BMI's corporate mission is to become the world's No.1 Independent Information Provider in its field (Country Risk & Industry Research).
Business Monitor International was founded in 1984 by Richard Londesborough and Jonathan Feroze, the company's joint CEOs, who both continue to play a full role within the company.
(Due to the lengths of the above URLs, it may be necessary to copy and paste these hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)
PR contact: Matthew Brooks Head of Strategic Analysis & Product Development Mermaid House 2 Puddle Dock London EC4V 3DS United Kingdom +44(0)20-7248-0468
SOURCE Business Monitor International